Drop in Cancer Diagnoses Under COVID-19 Raises Alarms
Results of a recent study support concerns that pandemic disruptions resulted in finding fewer cancers.
Progress Against Cancer
Results of a recent study support concerns that pandemic disruptions resulted in finding fewer cancers.
In the span of a decade, the idea that tumor-derived molecules circulating in the bloodstream and other body fluids could be leveraged to reveal the presence of cancer and monitor its course has become...
Researchers find that lung cancer patients recovering from surgery are especially vulnerable to the health hazards of wildfires even up to a year later.
Study suggests surgery leads to longer survival than radiation for non-small cell lung cancer, but radiation remains an important option.
Improved patient outcomes come from new treatments. New treatments stem from successful clinical trials. Clinical trials build on discoveries made in the lab. And laboratory discoveries? Those rely on a vast array of assays...
Researchers find increased risk of four types of secondary cancer in patients diagnosed with early-onset colorectal cancer.
Antibody-drug conjugates link a targeted medication with a toxic drug to deliver a potent payload inside cancer cells.
New treatments aim to lengthen remissions and push back recurrences.
Young women who have had hormone receptor-positive breast cancer can safely suspend endocrine therapy to try to have a child.
Adoptive T-cell therapy shows promise in treating metastatic melanoma.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn MoreYour donation to the American Association for Cancer Research helps our more than 54,000 members worldwide drive progress against cancer.
Donate Now